Literature DB >> 27719666

Cannabis: A Treasure Trove or Pandora's Box?

Katalin Solymosi1, Attila Köfalvi2.   

Abstract

BACKGROUND &
OBJECTIVE: Cannabis is one of the earliest cultivated plants. Cannabis of industrial utility and culinary value is generally termed as hemp. Conversely, cannabis that is bred for medical, spiritual and recreational purposes is called marijuana. The female marijuana plant produces a significant quantity of bio- and psychoactive phytocannabinoids, which regained the spotlight with the discovery of the endocannabinoid system of the animals in the early 90's. Nevertheless, marijuana is surrounded by controversies, debates and misconceptions related to its taxonomic classification, forensic identification, medical potential, legalization and its long-term health consequences.
METHOD: In the first part, we provide an in-depth review of the botany and taxonomy of Cannabis. We then overview the biosynthesis of phytocannabinoids within the glandular trichomes with emphasis on the role of peculiar plastids in the production of the secreted material. We also compile the analytical methods used to determine the phytocannabinoid composition of glandular trichomes. In the second part, we revisit the psychobiology and molecular medicine of marijuana. RESULTS &
CONCLUSION: We summarize our current knowledge on the recreational use of cannabis with respect to the modes of consumption, short-term effects, chronic health consequences and cannabis use disorder. Next, we overview the molecular targets of a dozen major and minor bioactive cannabinoids in the body. This helps us introduce the endocannabinoid system in an unprecedented detail: its up-todate molecular biology, pharmacology, physiology and medical significance, and beyond. In conclusion, we offer an unbiased survey about cannabis to help better weigh its medical value versus the associated risks. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Addiction; Cannabis sativa/indica; cannabis use disorder; endocannabinoid system; phytocannabinoid synthesis; psychosis; synaptic plasticity; tetrahydrocannabinol

Mesh:

Substances:

Year:  2017        PMID: 27719666     DOI: 10.2174/1389557516666161004162133

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  22 in total

1.  Transient gain of function of cannabinoid CB1 receptors in the control of frontocortical glucose consumption in a rat model of Type-1 diabetes.

Authors:  Joana Reis Pedro; Liane I F Moura; Ângela Valério-Fernandes; Filipa I Baptista; Joana M Gaspar; Bárbara S Pinheiro; Cristina Lemos; Fernanda Neutzling Kaufmann; Carla Morgado; Carla S da Silva-Santos; Isaura Tavares; Samira G Ferreira; Eugénia Carvalho; António F Ambrósio; Rodrigo A Cunha; João M N Duarte; Attila Köfalvi
Journal:  Brain Res Bull       Date:  2020-05-16       Impact factor: 4.077

2.  CB1 Receptors Mediated Inhibition of ATP-Induced [Ca2+]i Increase in Cultured Rat Spinal Dorsal Horn Neurons.

Authors:  Jingdong Long; Xiaolu Lei; Meiyun Chen; Shulei Yang; Tao Sun; Junwei Zeng; Deqian Yu; Hong Tian; Xiaohong Liu
Journal:  Neurochem Res       Date:  2017-11-10       Impact factor: 3.996

3.  Cannabinoids Induce Cell Death and Promote P2X7 Receptor Signaling in Retinal Glial Progenitors in Culture.

Authors:  Hércules Rezende Freitas; Alinny Rosendo Isaac; Thayane Martins Silva; Geyzzara Oliveira Ferreira Diniz; Yara Dos Santos Dabdab; Eduardo Cosendey Bockmann; Marília Zaluar Passos Guimarães; Karin da Costa Calaza; Fernando Garcia de Mello; Ana Lucia Marques Ventura; Ricardo Augusto de Melo Reis; Guilherme Rapozeiro França
Journal:  Mol Neurobiol       Date:  2019-03-05       Impact factor: 5.590

4.  Chronic insulinopenia/hyperglycemia decreases cannabinoid CB1 receptor density and impairs glucose uptake in the mouse forebrain.

Authors:  Liane I F Moura; Cristina Lemos; Catherine Ledent; Eugénia Carvalho; Attila Köfalvi
Journal:  Brain Res Bull       Date:  2019-02-02       Impact factor: 4.077

5.  Systematic review of structural and functional neuroimaging studies of cannabis use in adolescence and emerging adulthood: evidence from 90 studies and 9441 participants.

Authors:  Sarah D Lichenstein; Nick Manco; Lora M Cope; Leslie Egbo; Kathleen A Garrison; Jillian Hardee; Ansel T Hillmer; Kristen Reeder; Elisa F Stern; Patrick Worhunsky; Sarah W Yip
Journal:  Neuropsychopharmacology       Date:  2021-11-27       Impact factor: 8.294

Review 6.  Mechanisms of Cannabinoids and Potential Applicability to Skin Diseases.

Authors:  Amber Cintosun; Irene Lara-Corrales; Elena Pope
Journal:  Clin Drug Investig       Date:  2020-04       Impact factor: 2.859

Review 7.  Cannabinoid Signaling in the Skin: Therapeutic Potential of the "C(ut)annabinoid" System.

Authors:  Kinga Fanni Tóth; Dorottya Ádám; Tamás Bíró; Attila Oláh
Journal:  Molecules       Date:  2019-03-06       Impact factor: 4.927

Review 8.  Targeting Cannabinoid Signaling in the Immune System: "High"-ly Exciting Questions, Possibilities, and Challenges.

Authors:  Attila Oláh; Zoltán Szekanecz; Tamás Bíró
Journal:  Front Immunol       Date:  2017-11-10       Impact factor: 7.561

9.  Chronic, intermittent treatment with a cannabinoid receptor agonist impairs recognition memory and brain network functional connectivity.

Authors:  Francisco M Mouro; Joaquim A Ribeiro; Ana M Sebastião; Neil Dawson
Journal:  J Neurochem       Date:  2018-09-27       Impact factor: 5.372

10.  Chronic cannabinoid exposure produces tolerance to the dopamine releasing effects of WIN 55,212-2 and heroin in adult male rats.

Authors:  Devan M Gomez; Thomas J Everett; Lindsey R Hamilton; Ajit Ranganath; Joseph F Cheer; Erik B Oleson
Journal:  Neuropharmacology       Date:  2020-10-25       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.